Skip to Content

Logo (Merck) 351 (Zontivity vorapaxar sulfate 2.5 mg (2.08 mg base))

Generic Name: vorapaxar

Pill imprint Logo (Merck) 351 has been identified as Zontivity vorapaxar sulfate 2.5 mg (2.08 mg base).

Zontivity is used in the treatment of peripheral arterial disease; thromboembolic disorder; prevention of atherothrombotic events and belongs to the drug class protease-activated receptor-1 antagonists. There is no proven risk in humans during pregnancy. Zontivity vorapaxar sulfate 2.5 mg (2.08 mg base) is not a controlled substance under the Controlled Substance Act (CSA).

Zontivity
Generic Name:
vorapaxar
Imprint:
Logo (Merck) 351
Strength:
vorapaxar sulfate 2.5 mg (2.08 mg base)
Color:
Yellow
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Protease-activated receptor-1 antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Manufacturer:
Merck Sharp & Dohme Corp.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide